ANEB — Anebulo Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- $70.11m
- $63.47m
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash | ||||
Cash and Short Term Investments | 3.02 | 20 | 14.5 | 11.2 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 0.004 | 0 | — | — |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 3.03 | 21.7 | 15.6 | 11.7 |
Total Assets | 3.03 | 21.7 | 15.6 | 11.7 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Current Liabilities | 0.224 | 0.242 | 0.513 | 1.07 |
Total Long Term Debt | ||||
Total Debt | ||||
Total Liabilities | 0.224 | 0.242 | 0.513 | 1.07 |
Non Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 2.8 | 21.4 | 15.1 | 10.6 |
Total Liabilities & Shareholders' Equity | 3.03 | 21.7 | 15.6 | 11.7 |
Total Common Shares Outstanding |